Lacosamide Eg

Lacosamide, the active ingredient in Lacosamide Eg, is an anti-epileptic presented as an oral dosage form for oral use. It is indicated for the treatment of partial‑onset seizures in patients with epilepsy. GNH USA supplies Lacosamide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anti‑epileptic drug used to control focal seizure activity. - Partial‑onset seizures (adults): Reduces seizure frequency when added to existing therapy in adult epilepsy patients. - Partial‑onset seizures (pediatric ≥4 years): Provides adjunctive seizure control in children four years of age and older. - Refractory focal epilepsy: Serves as an adjunctive option for patients whose seizures are not adequately controlled by other medications.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness: Sensation of light‑headedness or unsteadiness. - Fatigue: Persistent tiredness or lack of energy. - Nausea: Stomach upset often accompanied by an urge to vomit. - Headache: Mild to moderate pain in the head region. - Blurred vision: Temporary loss of visual clarity.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: Prolongation of the PR interval that may lead to arrhythmias. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts or behavior: Emergence of depressive symptoms or self‑harm ideation.

Before initiating therapy, consider the following safety measures. - Cardiac conduction: Obtain baseline ECG and monitor for PR‑interval changes. - Renal impairment: Assess renal function; dose adjustment may be required. - Pregnancy: Safety not established; use only if potential benefit outweighs risk. - Driving and operating machinery: Counsel patients about possible dizziness or visual disturbances. - Concomitant medications: Review all drugs for potential interactions that may affect cardiac or CNS safety. - Store below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): May increase lacosamide plasma concentrations. - Other sodium‑channel blockers (e.g., carbamazepine, phenytoin): Heightened risk of cardiac conduction effects.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inducers (e.g., rifampin, carbamazepine): May reduce lacosamide levels. - Concomitant use with antihypertensives: Potential additive hypotensive effect. - Alcohol or CNS depressants: May enhance sedation or dizziness.